Your Legs Feel Heavy, Your Hands Go Numb. Here's the Biological Reason.

Factor V is a clotting protein that your body produces naturally. Its job is to thicken blood quickly when you’re injured, preventing excessive bleeding. It works as part of a tightly regulated cascade: start the clot, stabilize it, then dissolve it when healing is complete.

The Factor V Leiden variant (R506Q), carried by roughly 5% of people with European ancestry, makes this clotting factor resistant to the body’s natural brake mechanism. Normally, a protein called activated protein C tells Factor V to stop working. With the Leiden variant, your blood doesn’t listen to this stop signal, and clotting continues longer than it should. The result is a 4- to 8-fold increase in venous thromboembolism risk (blood clots in veins). If you also take oral contraceptives, the risk jumps to roughly 80-fold.

You feel this as heaviness in your legs, swelling, or a sensation that blood isn’t moving freely through your veins. In severe cases, it’s a warm, painful calf or chest pain (warning signs of a clot). Most people never develop a clot, but your circulation is compromised at the cellular level, and your risk is permanently elevated.

Prothrombin (Factor II) is another critical clotting protein. It’s activated in the cascade and sets off the final steps of blood thickening. Your genes control how much prothrombin you make. If you make too much, your blood becomes hypercoagulable, meaning it clots more easily than it should.

The G20210A variant, present in roughly 2-3% of people with European ancestry, causes your body to produce elevated levels of prothrombin. This increases your blood clotting risk by 2- to 3-fold, and the effect compounds if you also carry other clotting variants like Factor V Leiden or PAI1 4G/4G. The combination of multiple variants can push your thrombosis risk into dangerous territory.

You experience this as a persistent heaviness or achiness in your legs, swelling that doesn’t improve with elevation, and sometimes a visible pattern of spider veins or varicose veins. Your blood is working too hard to clot, and even at rest, your veins feel congested.

MTHFR (methylenetetrahydrofolate reductase) converts dietary folate into its active form, methylfolate. This active form is essential for creating and recycling methyl groups, which your body uses to regulate hundreds of processes, including homocysteine metabolism. Homocysteine is an amino acid; at healthy levels it’s harmless, but when it accumulates, it damages blood vessel walls and promotes clot formation.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces enzyme efficiency by 40-70%. This impairs your ability to clear homocysteine from your bloodstream. Even if you eat plenty of folate and B12, your cells can’t convert them into the forms they need. The result is elevated homocysteine, which is an independent cardiovascular risk factor that directly contributes to poor circulation, atherosclerosis, and clot formation.

You feel this as a low-grade ache in your legs that worsens over time, cold extremities that don’t warm up easily, and sometimes a mild tingling or numbness. Your circulation isn’t acutely blocked, but it’s chronically compromised by ongoing vascular inflammation and clot-promoting effects.

Once your body forms a clot and healing begins, it needs to dissolve that clot. Plasmin is the enzyme that does this dissolving. PAI1 (plasminogen activator inhibitor-1) regulates plasmin. Too much PAI1, and your body can’t break down clots efficiently. They persist, compress blood vessels, and impair circulation.

The PAI1 4G/5G polymorphism is one of the most common clotting variants. People with the 4G/4G genotype, roughly 25% of the population, produce elevated PAI1 levels. This slows clot dissolution and increases your risk of thrombotic events and cardiovascular complications. The effect is particularly pronounced during inflammation, illness, or stress, when PAI1 levels naturally rise. Your baseline is already high, so any physiological stress pushes you into dangerous territory.

You experience this as leg heaviness that improves slightly with movement but never fully resolves, bruising more easily than others, and a sensation that your blood is sluggish. Your veins feel full and congested because clots aren’t being broken down quickly enough.

Nitric oxide (NO) is a signaling molecule your blood vessel walls produce. It tells blood vessels to relax and dilate, increasing blood flow and lowering pressure. Without adequate nitric oxide, blood vessels constrict, blood pressure rises, and oxygen delivery to tissues declines. This is fundamental to good circulation.

The NOS3 Glu298Asp variant (rs1799983), carried by roughly 30-40% of people, reduces nitric oxide production. Your blood vessels don’t relax as much as they should, staying in a partially constricted state. This raises baseline blood pressure, reduces oxygen delivery to your extremities, and increases the shear stress on artery walls, promoting atherosclerosis and clot formation. It’s a double hit: both reduced circulation and increased clotting risk.

You notice this as cold hands and feet even in warm environments, legs that feel heavy or crampy after minimal activity, and sometimes a flushed or pale appearance depending on how your vessels respond. Your circulation feels constrained, as if your blood vessels don’t want to open up fully.

Vitamin K is essential for producing several clotting factors, including prothrombin (F2) and Factor V. Your body activates vitamin K by recycling it repeatedly; VKORC1 (vitamin K epoxide reductase complex 1) catalyzes this recycling. If VKORC1 function is reduced, your body can’t recycle vitamin K efficiently, meaning you need more dietary vitamin K to maintain normal clotting.

VKORC1 variants, common in all populations with roughly 50% carrying at least one copy, alter how efficiently you recycle vitamin K and thus how sensitive you are to vitamin K intake and warfarin dosing. Some variants make you require higher doses of warfarin or other anticoagulants; others make you more sensitive. Without knowing your VKORC1 status, anticoagulation therapy becomes a guessing game, and poor dosing leads to either clotting (if underdosed) or bleeding (if overdosed).

You might not feel VKORC1 effects directly, but they show up as unexplained bruising, excessive bleeding from minor cuts, or if you’re on anticoagulation therapy, difficulty achieving stable INR (the measure of clotting time). Your circulation is fine, but your body’s ability to regulate clotting factors is compromised.